S62C (p.Ser62Cys) variant of KRT17 (Keratin, type I cytoskeletal 17)

S62C (p.Ser62Cys) in KRT17 (Keratin, type I cytoskeletal 17) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.38 / 1. The record also includes population frequency data and structural context.

S62C (p.Ser62Cys) variant details